Kalaris Therapeutics (NASDAQ:KLRS) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Kalaris Therapeutics (NASDAQ:KLRS – Free Report) from a sell rating to a hold rating in a research note published on Tuesday. Kalaris Therapeutics Trading Down 4.1% Shares of NASDAQ:KLRS opened at $2.56 on Tuesday. Kalaris Therapeutics has a 1 year low of $2.45 and a 1 year high of […]
Wall Street Zen upgraded shares of Kalaris Therapeutics (NASDAQ:KLRS – Free Report) from a sell rating to a hold rating in a research note published on Tuesday. Kalaris Therapeutics Trading Down 4.1% Shares of NASDAQ:KLRS opened at $2.56 on Tuesday. Kalaris Therapeutics has a 1 year low of $2.45 and a 1 year high of […]
